test group:The antithrombotic treatment plan of the control group + Naoxintong capsule, orally. 4 capsules at a time, 3 times a day.

A multi-center, randomized controlled clinical evaluation study of Naoxintong Capsules for improving the quality of life of patients with non-valvular atrial fibrillation after PCI

Clinical Evaluation of Naoxintong Capsule for Improving the Quality of Life of Patients with Nonvalvular Atrial Fibrillation after PCI